NT-proBNP soon on turbidimetric analysers

The Gentian NT-proBNP assay is an in vitro diagnostic assay for the quantitative measurement of N-terminal pro-brain natriuretic peptide (NT-proBNP).

Gentian's proprietary antibody and nanoparticle-based technology allows measurement of a low-concentration NT-proBNP on fast, cost-effective and high-volume clinical analysers with no biotin interference.

This test fulfils the need for accurate and rapid diagnosis of cardiac diseases to improve patient outcomes, and at the same time improves the laboratory productivity.


Turbidimetric cardiac gold standard biomarker

Benefits of the Gentian Turbidimetric NT-
proBNP Assay

  • The immunossay is run on open clinical chemistry analysers independent of the platform provider
  • Measures concentrations in the range down to ng/L levels
  • Offers the same accurate diagnostic results as available chemiluminescence immunoassay analysers
  • No biotin interference


Contact us now to learn more

Want to know more about our NT-proBNP immunoassay launching in 2022? Please send us an email to or fill out the form below and the Product Manager for NT-proBNP will get in touch: